Ruijin Hospital: Leukemia, Myeloid, Acute trials

The registry lists 10 Leukemia, Myeloid, Acute studies with Ruijin Hospital as lead sponsor. 9 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 5Phase 3 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Mitoxantrone Hydrochloride Liposome, Cytarabine, G-CSF Plus Venetoclax vs. Azacitidine Plus Venetoclax for MDS-IB2 and Secondary/Elderly AMLNot yet recruitingNCT07735117Phase 3
• Ivosidenib as Maintenance Therapy in Transplant-Ineligible IDH1-mutated AML and HR-MDSRecruitingNCT07607418Phase 2
• Study of SA+X in the Treatment of Newly Diagnosed AMLRecruitingNCT07548710Phase 2
• Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute LeukemiaNot yet recruitingNCT07087847Not applicable
• VAM in Secondary AML, AML With Extramedullary Involvement, and Myeloid SarcomaRecruitingNCT07028086Phase 2
• Molecular Subtype Combined with Early Minimal Residual Disease to Optimize the Treatment of Newly Diagnosed Acute Myeloid LeukemiaNot yet recruitingNCT06652685Phase 2
• The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid LeukemiaRecruitingNCT06458257
• The Efficacy of Allo-HSCT in ND HR-CBF-AMLRecruitingNCT06458244
• A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AMLRecruitingNCT06329999Not applicable
• Decitabine Combined With Unrelated Cord Blood Transplantation for Elderly Patients With AMLStatus unknownNCT03913312Phase 1/2